mécanismes moléculaires de l'hypertrophie ventriculaire gauche

More documents

Recommendations

Info

234 G. CHOUKROUN ET COLL.17. WYNNE J, BRAUNWALD E. The cardiomyopathies and myocarditides. In Heart disease. E Braunwald,editor. Saunders, Philadelphia, 1997, 1404-1463.18. BONNE G, CARRIER L, RICHARD P et al. Familial hypertrophic cardiomyopathy : from mutations tofunctional defects. Circ Res, 1998, 83, 580-593.19. DAVIES MJ, KRIKLER DM. Genetic investigation and counselling of families with hypertrophiccardiomyopathy. Br Heart J, 1994, 72, 99-101.20. VIKSTROM KL, LEINWAND LA. Contractile protein mutations and heart disease. Curr Opin CellBiol, 1996, 8, 97-105.21. JAMES J, ROBBINS J. Molecular remodeling of cardiac contractile function. Am J Physiol, 1997,273, H2105-H2118.22. CHIEN KR. Stress pathways and heart failure. Cell, 1999, 98, 555-558.23. SCHWARTZ K, MERCADIER JJ. Molecular and cellular biology of heart failure. Curr Opin Cardiol,1996, 11, 227-236.24. ANVERSA P, RICCI R, OLIVETTI G. Quantitative structural analysis of the myocardium during physiologicgrowth and induced cardiac hypertrophy : a review. J Am Coll Cardiol, 1986, 7, 1140-1149.25. GROSSMAN W. Diastolic dysfunction in congestive heart failure. N Engl J Med, 1991, 325, 1557-1564.26. COLUCCI WC, BRAUNWALD E. Pathophysiology of heart failure. In Heart disease. E Braunwald,editor. Saunders, Philadelphia, 1997, 394-419.27. DEVEREUX RB. Hypertensive cardiac hypertrophy. Pathophysiologic and clinical characteristics. InHypertension : pathophysiology, diagnosis, and management. JH Laragh, and BM Brenner, editors.Raven Press, Ltd, New York, 1990, 359-377.28. CHIEN KR. Molecular advances in cardiovascular biology. Science, 1993, 260, 916-917.29. VAN HEUGTEN HAA, LAMERS JMJ. Changes in cardiac phenotype in hypertrophy and failure : fromreceptor to gene. Heart Failure Reviews, 1997, 2, 95-106.30. SCHWARTZ K, BOHELER KR, DE LA BASTIE D et al. Switches in cardiac muscle gene expression asa result of pressure and volume overload. Am J Physiol, 1992, R364-R369.31. CHIEN KR, KNOWLTON KU, ZHU H et al. Regulation of cardiac gene expression during myocardialgrowth and hypertrophy : molecular studies of an adaptive physiologic response. Faseb J, 1991, 5,3037-3046.32. CHIEN KR, GRACE A, HUNTER J. Molecular basis of cardiac hypertrophy and heart failure. In MolecularBasis of Heart Disease. K Chien, editor. Saunders, WB, Philadelphia, 1997.33. FORCE T, ALESSANDRINI A, BONVENTRE JV. Cell signaling. In The Kidney : Physiology and Pathophysiology.D. W. Seldin, and G. Giebisch, editors. Lippincott-Raven, Philadelphia, 1999.34. SUGDEN PH, CLERK A. « Stress-responsive » mitogen-activated protein kinases (c-Jun N-terminalkinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res, 1998, 83, 345-352.35. OPIE L. Overload hypertrophy and its molecular biology. In The Heart. L Opie, editor. LippincottWilliams and Wilkins, Philadelphia, 1998, 391-418.36. CLERK A, SUGDEN PH. Cell stress-induced phosphorylation of ATF2 and c-Jun transcription factorsin rat ventricular myocytes. Biochem J, 1997, 325, 801-810.37. CROZATIER B. Stretch-induced modifications of myocardial performance : from ventricular functionto cellular and molecular mechanisms. Cardiovasc Res, 1996, 32, 25-37.38. SADOSHIMA J, IZUMO S. The cellular and molecular response of cardiac myocytes to mechanicalstress. Annu Rev Physiol, 1997, 59, 551-571.39. YAMAZAKI T, KOMURO I, KUDOH S et al. Angiotensin II partly mediates mechanical stress-inducedcardiac hypertrophy. Circ Res, 1995, 77, 258-265.40. NEER EJ. Heterotrimeric G proteins : organizers of transmembrane signals. Cell, 1995, 80, 249-257.41. SUGDEN PH, CLERK A. Regulation of the ERK subgroup of MAP kinase cascades through G proteincoupledreceptors. Cell Signal, 1997, 9, 337-351.42. RHEE SG, BAE YS. Regulation of phosphoinositide-specific phospholipase C isozymes. J BiolChem, 1997, 272, 15045-15048.43. KENTISH JC, BARSOTTI RJ, LEA TJ et al. Calcium release from cardiac sarcoplasmic reticulum inducedby photorelease of calcium or Ins (1,4,5) P3. Am J Physiol, 1990, 258, H610-H615.
MÉCANISMES MOLÉCULAIRES DE L’HYPERTROPHIE VENTRICULAIRE GAUCHE 23544. NEUMANN J, SCHMITZ W, SCHOLZ H et al. Increase in myocardial Gi-proteins in heart failure. Lancet,1988, 2, 936-937.45. BOHM M, GIERSCHIK P, KNORR A et al. Desensitization of adenylate cyclase and increase of Gialpha in cardiac hypertrophy due to acquired hypertension. Hypertension, 1992, 20, 103-112.46. VATNER D, SATO N, GALPER J et al. Physiological and biochemical evidence for coordinateincreases in muscarinic receptors and Gi during pacing-induced heart failure. Circulation, 1996,94, 102-107.47. LAMORTE VJ, THORBURN J, ABSHER D et al. Gq- and ras-dependent pathways mediate hypertrophyof neonatal rat ventricular myocytes following alpha 1-adrenergic stimulation. J Biol Chem, 1994,269, 13490-13496.48. MENDE U, KAGEN A, COHEN A et al. Transient cardiac expression of constitutively active Gαqleads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independentpathways. Proc Natl Acad Sci USA, 1998, 95, 13893-13898.49. D’ANGELO D, SAKATA Y, LORENS JN et al. Transgenic Gαq overexpression induces cardiaccontractile failure in mice. Proc Natl Acad Sci USA, 1997, 94, 8121-8126.50. AKHTER SA, LUTTRELL LM, ROCKMAN HA et al. Targeting the receptor-Gq interface to inhibit invivo pressure overload myocardial hypertrophy. Science, 1998, 280, 574-577.51. MELLOR H, PARKER PJ. The extented protein kinase C superfamily. Biochem J, 1998, 332, 281-292.52. GU X, BISHOP S. Increased protein kinase C and isozyme redistribution in pressure-overload cardiachypertrophy in the rat. Cir Res, 1994, 75, 926-931.53. MOLKENTIN JD, DORN II GW2nd. Cytoplasmic signaling pathways that regulate cardiac hypertrophy.Annu Rev Physiol, 2001, 63, 391-426.54. ZOU Y, KOMURO I, YAMAZAKI T et al. Protein kinase C, but not tyrosine kinases or Ras, plays acritical role in Angiotensin II-induced activation of Raf-1 kinase and extracellular signal-regulatedprotein kinases in cardiac myocytes. J Biol Chem, 1996, 271, 33592-33597.55. FORCE T, POMBO CM, AVRUCH JA et al. Stress-activated protein kinases in cardiovascular disease.Circ Res, 1996, 78, 947-953.56. FORCE T, BONVENTRE JV. Growth factors and mitogen-activated protein kinases. Hypertension,1998, 31, 152-161.57. KYRIAKIS JM, AVRUCH J. Protein kinase cascades activated by stress and inflammatory cytokines.BioEssays, 1996, 18, 567-577.58. KYRIAKIS JM, BANERJEE P, NIKOLAKAKI E et al. The stress-activated protein kinase subfamily ofc-Jun kinases. Nature, 1994, 369, 156-160.59. COHEN P. The search for physiological substrates of mitogen- and stress-activated protein kinasesin mammalian cells. Trends Cell Biol, 1997, 7, 353-361.60. SUGDEN PH, CLERK A. “Stress responsive” mitogen-activated protein kinases (C-jun N- terminalkinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res, 1998, 83, 345-352.61. CLERK A, BOGOYEVITCH MA, ANDERSON MB et al. Differential activation of protein kinase C isoformsby endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogenactivatedprotein kinases in ventricular myocytes cultured from neonatal rat hearts. J Biol Chem,1994, 269, 32848-32857.62. BOGOYEVITCH MA, GILLESPIE BJ, KetTerman AJ et al. Stimulation of the stress-activated mitogenactivatedprotein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinasesand c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res, 1996, 79, 162-173.63. GILLESPIE-BROWN J, FULLER SJ, BOGOYEVITCH MA et al. The mitogen-activated protein kinasekinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in ratventricular cardiomyocytes. J Biol Chem, 1995, 270, 28092-28096.64. THORBURN J, CARLSON M, MANSOUR SJ et al. Inhibition of a signaling pathway in cardiac musclecells by active mitogen-activated protein kinase kinase. Mol Biol Cell, 1995, 6, 1479-1490.65. THORBURN J, MCMAHON M, THORBURN A. Raf-1 kinase activity is necessary and sufficient forgene expression changes but not sufficient for cellular morphology changes associated with cardiacmyocyte hypertrophy. J Biol Chem, 1994, 269, 30580-30586.66. CHOUKROUN G, HAJJAR R, KYRIAKIS JM et al. Role of the stress-activated protein kinases in endothelin-inducedcardiomyocyte hypertrophy. J Clin Invest, 1998, 102, 1311-1320.
Page 1 and 2: MÉCANISMES MOLÉCULAIRES DE L’HY
Page 13: MÉCANISMES MOLÉCULAIRES DE L’HY

mécanismes moléculaires de l'hypertrophie ventriculaire gauche

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?